Table 2.
Functional and biochemical markers of performance and recovery in absolute values. Values are expressed as mean, standard deviations (± SDs) and confidence intervals
| Variable | Group | Baseline | Immediately after | 1 h | 24 h | 48 h | 72 h |
|---|---|---|---|---|---|---|---|
|
MVC (Nm) |
Placebo | 228.28 (± 30.27) | 177.21 (± 27.33) | 172.98 (± 29.38) | 171.21 (± 29.40) | 167.65 (± 29.80) | 193.15 (± 29.95) |
| [209.52–247.04] | [160.27–194.14] | [154.77–191.19] | [152.99–189.43] | [149.18–186.12] | [174.59–211.71] | ||
| Local | 231.72 (± 34.74) | 213.54 (± 32.58)b | 203.03 (± 30.23)b | 213,74 (± 32.48)a,b | 225.30 (± 29.45)a,b | 249.59 (± 37.58)a,b | |
| [210.19–253.25] | [193.35–233.73] | [184.29–221.77] | [193.61–233.87] | [207.05–243.55] | [226.30–272.88] | ||
| Non-local | 213.11 (± 30.04) | 171.93 (± 29.88) | 155.63 (± 25.18) | 164.56 (± 21.51) | 181.08 (± 30.32) | 178.74 (± 21.74) | |
| [194.49–231.73] | [153.41–190.45] | [140.02–171.24] | [151.23–177.89] | [162.29–199.87] | [165.27–192.21] | ||
|
CK (U.L−1) |
Placebo | 43.87 (± 16.28) | 43.31 (± 15.16) | 58.51 (± 20.73) | 162.31 (± 56.01) | 234.97 (± 87.49) | 233.60 (± 94.19) |
| [33.78–53.96] | [33.91–52.71] | [45.66–71.36] | [127.60–197.02] | [180.74–289.20] | [175.22–291.98] | ||
| Local | 38.20 (± 11.29) | 34.70 (± 12.83) | 35.38 (± 15.34) | 69.83 (± 30.35) a,b | 74.80 (± 35.68)a,b | 54.53 (± 28.85) a,b | |
| [31.20–45.20] | [26.75–42.65] | [25.87–44.89] | [51.02–88.64] | [52.69–96.91] | [36.65–72.41] | ||
| Non-local | 50.49 (± 12.89) | 49.74 (± 15.09) | 59.62 (± 16.02) | 168.98 (± 61.69) | 252.83 (± 118.01) | 296.81 (± 88.28) | |
| [42.50–58.48] | [40.39–59.09] | [49.69–69.55] | [130.74–207.22] | [179.69–325.97] | [242.09–351.53] | ||
|
DOMS (VAS - mm) |
Placebo | 0 (± 0) | 13.10 (± 7.56) | 37.40 (± 17.42) | 49.70 (± 14.25) | 52.30 (± 20.12) | 50.60 (± 20.38) |
| [0–0] | [8.40–17.80] | [26.60–48.20] | [40.80–58.60] | [39.80–64.80] | [38.00–63.20] | ||
| Local | 0 (± 0) | 21.40 (± 14.17) | 12.30 (± 14.28) a,b | 16.60 (± 15.59) a,b | 23.20 (± 17.83) a,b | 20.40 (± 15.49) a,b | |
| [0–0] | [12.60–30.30] | [3.40–21.20] | [6.90–26.30] | [12.20–34.20] | [10.80–30.00] | ||
| Non-local | 0 (± 0) | 21.70 (± 11.45) | 42.40 (± 25.65) | 54.50 (± 30.70) | 65.90 (± 27.98) | 57.20 (± 31.14) | |
| [0–0] | [14.60–28.80] | [26.50–58.30] | [35.50–73.50] | [48.50–83.30] | [37.90–76.50] | ||
|
Lactate (mmol. L− 1) |
Placebo | 2.45 (± 0.83) | 4.73 (± 1.47) | 2.30 (± 0.84) | |||
| [1.94–2.96] | [3.82–5.64] | [1.78–2.82] | – | – | – | ||
| Local | 2.56 (± 0.44) | 3.35 (± 0.76) a,b | 2.14 (± 0.33) | ||||
| [2.29–2.83] | [2.88–3.82] | [1.94–2.34] | – | – | – | ||
| Non-local | 2.06 (± 0.52) | 4.62 (± 1.67) | 2.31 (± 0.60) | ||||
| [1.74–2.38] | [3.58–5.66] | [1.94–2.68] | – | – | – |
aDifferent compared to Placebo group (p < 0.05)
bDifferent compared to Non-local group (p < 0.05)